Agoracom Blog Home

Posts Tagged ‘CSE’

TransCanna $TCAN.ca Appoints Construction & Farming Expert to Board of Directors and Provides MCTO Update $VFF.ca $ACB.ca $GTII.ca $TEQ.ca

Posted by AGORACOM at 3:45 PM on Wednesday, April 14th, 2021
tcan-square
  • Commercial farming and construction expert Josh Baker joins TransCanna’s Board of Directors
  • “I’m extremely excited to join TransCanna, and would not have joined if I didn’t see the tremendous potential here,” said Mr. Baker. “I really see it becoming one of the greatest cannabis companies in California in the next three years.”

Vancouver, British Columbia–(Newsfile Corp. – April 14, 2021) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce the appointment of commercial farming and construction expert, Josh Baker, to its Board of Directors today.

The appointment comes in conjunction with the Company’s first draw down of its recently secured $2M construction loan. Mr. Baker is the US-based lender’s nominee to the Board, who will provide guidance and stewardship while the loan is deployed to increase production capacity at the Company’s Daly Facility in Modesto, California.

Mr. Baker brings a wealth of relevant experience to the Board. He is a 6th generation farmer local to the Central Valley, with decades of experience building and operating commercial and residential family farms, giving him an intimate understanding of everything that goes into agricultural construction and how to optimally and efficiently grow and market crops.

As the Board Member representing the lender’s interests, Mr. Baker will monitor the construction project and confirm when each phase is complete.

Phase One, currently underway, includes the construction of a 6,000 sq ft vegetative room, and five new cultivation rooms that can produce up to 200 lbs of harvest every two weeks.

“I’m extremely excited to join TransCanna, and would not have joined if I didn’t see the tremendous potential here,” said Mr. Baker. “The $2M construction loan will help bring it to profitability, and I really see it becoming one of the greatest cannabis companies in California in the next three years.”

Bob Blink, Company CEO, said, “Everyone has hit the ground running with this new loan. As of today, we already have new construction workers at the facility, and expect to have plants in the new cultivation rooms within the next three weeks.”

MCTO Update

The Company wishes to provide an update with respect to the previously announced Management Cease Trade Order (the “MCTO”) issued by the British Columbia Securities Commission on March 31, 2021. The MCTO was issued in connection with the delay by the Company in filing its annual financial statements, management’s discussion and analysis and related officer certifications for the financial year ended November 30, 2020 (collectively, the “Required Filings”) before the prescribed deadline of March 30, 2021. The Company continues to work closely with its auditor and expects to file the Required Filings on or before May 31, 2021.

The Company is providing this status update in accordance with National Policy 12-203 Management Cease Trade Orders (“NP 12-203”). The Company intends to follow the provisions of the Alternative Information Guidelines set out in NP 12-203, including the issuance of bi-weekly default status reports in the form of news releases. The Company confirms as of the date of this news release that there has been no material change in the information contained in the announcement issued on April 1, 2021, and there is no other material information concerning the affairs of the Company that has not been generally disclosed.

$ITM $ITMF $ITM.ca Signs Letter of Intent to Acquire Advertiise Technologies Inc. $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

Posted by AGORACOM at 2:18 PM on Wednesday, April 14th, 2021
This image has an empty alt attribute; its file name is ITM-square-600x600.jpg
  • Advertiise acquisition to complement Intema’s eFlyerMaker and HypeX.gg marketing services with a leading global online advertising marketplace.
  • Acquisition to be accretive to Intema’s revenues: Advertiise has over 25,000 users from 40 countries, over 150,000 global advertising listings, and over 135 million daily advertising impressions.
  • Advertiise ranked #1 in Google SEO for 3 years in a row and was selected as a finalist in 2016 in StartUp Canada, and one of the Top10 Canadian Startups in 2017.
  • Current size of the advertising industry worldwide is US$600 billion and continues to grow 4-6% annually.1

MONTREAL, April 14, 2021 (GLOBE NEWSWIRE) — Intema Solutions Inc. (“Intema” or the “Corporation”) (TSXV: ITM, OTCMKTS: ITMZF) is pleased to announce that it has entered into a letter of intent on April 13, 2021 to acquire all of the issued and outstanding securities of Advertiise Technologies Inc. (“Advertiise”), a private corporation among the first mover in peer-to-peer advertising marketplace development and is evolving the advertising industry via blockchain and AI technologies (the “Acquisition”).

Advertiise® is a global online advertising marketplace that connects media buyers and media suppliers across all advertising channels without the need for an intermediary. It allows media sellers to list, price and promote real-time inventory of media assets, including asset attributes (traffic/views/etc.). Media buyers benefit from the ability to access a real-time inventory of media assets tailored to their advertising needs and transact through the platform. Advertiise was a first mover in peer-to-peer advertising marketplace development and is evolving the advertising industry by providing a trustworthy, intuitive desktop/mobile experience, supported by SaaS infrastructure and blockchain and AI technologies. Originally launched in Canada in 2017, Advertiise now operates in multiple international markets, and continues to expand globally with a focus on its marketplace: advertiise.com

For the year ended March 31, 2020 Advertiise’s predecessor entity non-audited financial statements reported total revenues of US$110,000 and net profits of US$46,000, and as of March 31, 2021, Advertiise had total assets of US$263,000, and total liabilities of US$380,000.

“Launched in February 2017, Advertiise, one of the Top10 Canadian Startups (2017) now has over 25,000 users in over 40 countries worldwide. They have been ranked #1 in Google SEO for 3 years in a row and were selected as a finalist (2016) in StartUp Canada. With over 135 million daily advertising impressions and growing, we strongly believe that this acquisition is fulfilling our commitment of creating an unparalleled digital experience. We are constantly evolving, growing and looking to expand our portfolio of interconnected tech platforms. With Advertiise and their exceptional team joining the Intema family, we are creating an ecosystem that will allow us to attract, engage and retain advertisers, affiliates, publishers, players and casual gamers,” said Laurent Benezra, President and CEO of Intema.

“We are excited to join the Intema team and their portfolio of companies. This partnership aligns with our strategic vision in working alongside strong digital media assets. Market conditions changed dramatically and suddenly in 2020. Nevertheless and against the pandemic headwind, Advertiise still managed to double its revenues and acquire strategic assets. We strongly intend to keep pushing and continue scaling revenues and customer acquisition in 2021 with a dedicated focus on digital media assets within the Esports media category,” said Mark Vella, CEO of Advertiise Technologies Inc.

Acquisition Terms

To acquire Advertiise on a cash-free, debt-free basis, Intema will: (i) issue 2 million common shares (each a “Share”) of the Corporation (the “Consideration Shares”), and (ii) pay a maximum earnout of CA$2.0 million, in cash or Shares at a price equal to the higher of the Market Price (as defined in the policies of the TSX Venture Exchange) and the 5-day volume weighted average price on the date preceding the payment at the option of Intema, subject to prior approval of the TSX Venture Exchange, based on Advertiise achieving the following revenue projections:

  1. in excess of CA$7.5 million during the 12-month period following the closing of the Acquisition (the “Closing Date”), the vendors will receive an earnout amount of CA$1.0 million;
  2. in excess of CA$11 million during the 12 to 24-month period following the Closing Date, the vendors will receive an additional earnout amount of CA$1.0 million.

The Consideration Shares to be issued to the vendors of Advertiise will be subject to a voluntary escrow pursuant to the following terms: (i) 25% may be sold four (4) months plus one (1) day from the Closing Date, (ii) 25% six (6) months following the Closing Date, and (iii) 25% on the nine (9) and twelve (12) months following the Closing Date.

In order to assist in the attainment of the yearly revenue targets, Intema will allocate a minimum working capital of CA$2.0 million to the operations of Advertiise.

The parties have agreed to undertake commercially reasonable efforts to close the Acquisition on or before April 30, 2021. The letter of intent terminates in the event the parties fail to complete the Acquisition on or prior to April 30, 2021, unless extended in writing by the parties.

The acquisition is at arm’s length and is subject to due diligence by Intema, the signing of a definitive agreement and approval by the regulatory authorities, including the TSX Venture Exchange.

To read more, click here.

AGORACOM Small Cap 60: Harborside $HBOR.ca $HBORF Wholesale Capabilities Growing Margins $VFF.ca $HARV.ca $ACB.ca

Posted by AGORACOM at 1:39 PM on Wednesday, April 14th, 2021
This image has an empty alt attribute; its file name is HBOR-square.jpg

FansUnite $FANS $FUNFF Provides Corporate Update $SCR.ca $BRAG.ca $GMBL

Posted by AGORACOM at 1:26 PM on Wednesday, April 14th, 2021
This image has an empty alt attribute; its file name is fans-square-300x300.jpg
  • McBookie’s gross gaming revenue was $982K CAD, a record for any quarter since inception and an increase of 136% as compared to the first quarter of 2020;
  • Gross margins increased by approximately 138% as compared to the first quarter of 2020; and
  • Total betting volume on the platform surpassed $28M CAD for the quarter

The first quarter of 2021 saw a record $28.3M in betting volume and a 136% increase in revenue for McBookie compared to the same period in 2020 as well as other key developments

Vancouver, British Columbia–(Newsfile Corp. – April 14, 2021) – FansUnite Entertainment Inc. (CSE: FANS) (OTCQB: FUNFF) (“FansUnite” or the “Company”) is pleased to provide the following corporate update for the first quarter of 2021.

McBookie’s Exceptional Growth

Betting volume on the sportsbook and casino for McBookie Ltd. (“McBookie”) increased significantly, setting new records.

  • McBookie’s gross gaming revenue was $982K CAD, a record for any quarter since inception and an increase of 136% as compared to the first quarter of 2020;
  • Gross margins increased by approximately 138% as compared to the first quarter of 2020; and
  • Total betting volume on the platform surpassed $28M CAD for the quarter

At its peak betting volume during the first quarter of 2021, McBookie had over 1,000 unique customers on the casino alone, as well as 23,000 bets placed in a single week on the sportsbook – the highest number of wagers in a week since its inception in 2009.

Other Key Developments

U.K. Gambling Licenses Application

FansUnite has applied for critical U.K. Gambling Licenses which are recognized as the gold standard for lawful sports betting and casino operations by gambling authorities worldwide. The U.K. Gambling Licenses would enable FansUnite to deploy its B2B Gaming solutions to betting operators and launch B2C wagering platforms in the leading U.K. online gambling market. The application is expected to be approved in the second quarter of 2021, subject to FansUnite meeting all applicable requirements.

Esports Sportsbook in the U.S.

The previously announced Esports sportsbook with Sky Ute Casino has undergone its private beta testing phase and is ready to be launched upon receiving final regulatory approval. The wagering system of the sportsbook has demonstrated the ability to meet all local requirements including remote server installation of FansUnite’s betting engine and player database, geofencing, player KYC and the successful integration of Sightline payments.

Askott Games Integration with The Ear Platform

Askott Games, a wholly-owned subsidiary of FansUnite has completed testing on its first four RNG games and delivered them to The Ear for integration. The Company is in The Ear development queue and will announce when the integration is complete and the first games go live. Now that 4 games have been completed, FansUnite is actively working on additional aggregator partnerships and is in development of their 5th RNG game.

“The first quarter of 2021 represents a key inflection point for us as we continue to hit new milestones,” said Scott Burton, CEO of FansUnite. “We are delighted to announce McBookie’s strong performance as well as the rapid expansion of our B2B operations in the North American and European market. Obtaining the U.K. gambling licenses, coupled with the completion of our esports wagering platform in Colorado and the full integration of Askott Games’ iGaming solutions will allow us to solidify our position as a leading global online betting company.”

To read more, click here.

KWESST $KWE.ca $KWEMF Announces Appointment of VP Operations and Full-Time Engagement of Existing CFO $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 9:28 AM on Wednesday, April 14th, 2021

  • Announced that it has appointed Rick Bowes, CD, MA, MBA in the new position of Vice President, Operations to oversee and accelerate market introduction of the Company’s products and services for Digitization and Tactical Products (“DTP”).
  • The DTP business unit comprises the bulk of the Company’s current products and services, including TASCS, ATAK integration, the GreyGhostTM micro missile against hostile drones, the laser defence system and the Phantom electronic decoy.
  • Appointments are part of KWESST’s expanded business plan

Ottawa, Ontario–(April 14, 2021) – KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) (“KWESST” or “the Company”) today announced that it has appointed Rick Bowes, CD, MA, MBA in the new position of Vice President, Operations to oversee and accelerate market introduction of the Company’s products and services for Digitization and Tactical Products (“DTP”). The DTP business unit comprises the bulk of the Company’s current products and services, including TASCS, ATAK integration, the GreyGhostTM micro missile against hostile drones, the laser defence system and the Phantom electronic decoy.

In conjunction, the Company also announced that Steve Archambault, who has been serving as part-time Chief Financial Officer since the Company’s listing in September 2020, will now assume this role on a full-time basis.

“With the expected closing of our recently announced $4 million over-subscribed brokered private placement, KWESST is positioned to execute on an expanded business plan,” said Jeff MacLeod, KWESST Founder, President and CEO. “The appointments announced today add bench strength for accelerated market introduction across our growing portfolio of products and services.”

“We are very pleased indeed to welcome Rick as VP Operations,” added David Luxton, Executive Chairman. “He brings a rare combination of senior defence industry experience and domain knowledge that is directly relevant to our key markets and programs. He also has proven business capture experience and long-standing relationships with major defence contractors. We are equally pleased that Steve Archambault has committed to the Company on a dedicated, full-time basis in the role of CFO.”

About Rick Bowes

Prior to his various senior roles with defence contractors such as General Dynamics Canada, DRS Technologies Canada (now Leonardo DRS), ATCO Frontec and ADGA Group Inc., Rick had a distinguished career as a senior officer in the Canadian Army, retiring in 2003 as a Lieutenant Colonel. He is a graduate of Royal Military College of Canada and served in various operational and staff roles in the Canadian military and on secondment to the British Army. As an armour officer, Rick served with various units such as Lord Strathcona’s Horse (Royal Canadians) and the Canadian Airborne Regiment Battle Group across Canada and in deployed operations in Bosnia-Herzegovina with the UN Protection Force and the NATO Stabilization Force (SFOR). Rick was also part of the planning team for Canada’s participation in the NATO Kosovo Force (KFOR) mission in 1999.

The Company stated that the terms of these appointments include a grant of 300,000 stock options to Rick Bowes, with each stock option being exercisable at a price equal to the closing price of the Company’s shares on the TSX Venture Exchange on April 16th, 2021 on or before April 13, 2026 and a grant of Restricted Share Units (“RSU”s) to Steve Archambault equal to $25,000 divided by the closing price of the Company’s shares on the TSX Venture Exchange on April 16th, 2021.

Read More: https://agoracom.com/ir/Kwesst/forums/discussion/topics/759024-kwesst-announces-appointment-of-vp-operations-and-full-time-engagement-of-existing-cfo/messages/2311873#message

PlantX $VEGA $PLTXF Adds Refrigerated and Frozen Foods to Its Online Grocery Selection $VERY.ca $MEAT.ca $EATS.ca $VEGN.ca

Posted by AGORACOM-JC at 9:13 AM on Wednesday, April 14th, 2021
  • Announced the addition of perishable, refrigerated and frozen goods to its expanding repertoire of grocery items
  • Company will be enhancing its product offerings by adding high-quality fresh and frozen products by various plant-based brands including Beyond Meat, Impossible Foods, Miyokos, Follow Your Heart, Gardein, Tofurkey and Alpha Foods
  • This move will allow PlantX to significantly increase its product assortment at its one-stop-shop for everything plant-based e-commerce platform

VANCOUVER, BC , April 14, 2021 – PlantX Life Inc. (CSE: VEGA ) (Frankfurt: WNT1) (OTCQB: PLTXF) (” PlantX ” or the ” Company “) is pleased to announce the addition of perishable, refrigerated and frozen goods to its expanding repertoire of grocery items.

The Company will be enhancing its product offerings by adding high-quality fresh and frozen products by various plant-based brands including Beyond Meat, Impossible Foods, Miyokos, Follow Your Heart, Gardein, Tofurkey and Alpha Foods. This move will allow PlantX to significantly increase its product assortment at its one-stop-shop for everything plant-based e-commerce platform. The new items are now available to order in the ‘ Frozen ‘ and ‘ Refrigerated’ sections of the Company’s United States’ e-commerce platform . Frozen and refrigerated products will be available for shipping to Canadian customers later this year.

Temperature monitoring is crucial in ensuring the freshness of refrigerated and frozen items. A high number of touch points in the supply chain can affect temperature management due to the repeated loading and unloading or prolonged transfer time, which can therefore compromise product quality. To assist in bypassing these challenges, PlantX has partnered with a logistics provider that will deliver the new products from manufacturers to consumers’ homes in an efficient manner.

“Launching the new refrigerated and frozen product line is a natural and thrilling next step for PlantX,” said Julia Frank , PlantX CEO. “By adding such items, we are building on our efforts to create an online presence where customers can access a versatile range of high-quality products that meet their everyday needs.”

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop-shop for everything plant-based. With its fast-growing category verticals, the Company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the Company currently has plans underway to expand its product lines to include cosmetics, clothing and its own water brand — but the business is not limited to an e-commerce platform. The Company uses its digital platform to build a community of like-minded consumers, and most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. The Company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life.

The Company website is http://investor.PlantX.com/ .

Read More: https://agoracom.com/ir/PlantX/forums/discussion/topics/759022-plantx-adds-refrigerated-and-frozen-foods-to-its-online-grocery-selection/messages/2311870#message

Else $BABY.ca $BABYF Signs Agreement to Expand into 159 Vitamin Cottage Stores Across 20 States $VERY.ca $MEAT.ca $EATS.ca $VEGN.ca

Posted by AGORACOM-JC at 8:50 AM on Wednesday, April 14th, 2021
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Announced that it will expand distribution of it Plant-Based Complete Nutrition for Toddlers into 159 Natural Grocers by Vitamin Cottage stores across 20 states as of May 2021

VANCOUVER, BC , April 14, 2021 – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY.V) (OTCQX: BABYF) (FSE: 0YL.F) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company , announces that it will expand distribution of it Plant-Based Complete Nutrition for Toddlers into 159 Natural Grocers by Vitamin Cottage stores across 20 states as of May 2021.

“Launching at Natural Grocers by Vitamin Cottage drives significant and strategic distribution for the brand. We are particularly excited by the alignment between this retailer and with our brand, both focusing on helping people through sustainable, organic nutrition solutions, said Hamutal Yitzhak , Else CEO and Co-Founder. “We are eager to bring real, organic and whole food-based, clean label solutions to families in this region,” she added.

About Natural Grocers by Vitamin Cottage

Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) is one of the leading natural food grocers in the US, with 159 stores in 20 states west of the Mississippi river. Founded in 1955, Natural Grocers is an expanding specialty retailer of natural and organic groceries, body care products, and dietary supplements. The products sold by Natural Grocers must meet strict quality guidelines and may not contain artificial colors, flavors, preservatives or sweeteners, or partially hydrogenated or hydrogenated oils. The Company sells only USDA certified organic produce and exclusively pasture-raised, non-confinement dairy products, and free-range eggs. Natural Grocers’ flexible smaller-store format allows it to offer affordable prices in a shopper-friendly, safe, and convenient retail environment. The Company also provides extensive free science-based Nutrition Education programs to help customers make informed health and nutrition choices.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan . Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board  members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies,  and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School , USA , Tel Aviv University , Schneider Children’s Medical Center of Israel , Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium .

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents.  Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate.  Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Valeo Pharma $VPH $VPHIF Announces $4.0 Million Non-Brokered Private Placement of Non-Convertible Debentures $HLS.ca $MDP.ca $GUD.ca $RX.ca

Posted by AGORACOM-JC at 8:44 AM on Wednesday, April 14th, 2021
  • Announced today a non-brokered private placement of up to 4,000 unsecured non-convertible debentures units (the “Debenture Units”) at a price of $1,000 per Debenture Unit for maximum gross proceeds of $4,000,000
  • Valeo insiders participate for $2.6 million

MONTREAL , April 14, 2021 – Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a Canadian pharmaceutical company, announced today a non-brokered private placement of up to 4,000 unsecured non-convertible debentures units (the “Debenture Units”) at a price of $1,000 per Debenture Unit for maximum gross proceeds of $4,000,000 (the “Offering”).

Each Debenture Unit will consist of one (1) unsecured non-convertible debenture of the Company in the principal amount of $1,000 (each, a “Debenture”) and 200 Class “A” share purchase warrants (each, a “Warrant”). Each Warrant will entitle the holder thereof to purchase one Class “A” Share of the Company (each, a “Share”) at an exercise price of $1.60 at any time up to 24 months following the closing date of the Offering (the “Closing Date”). The Debentures will mature at the latest 9 months after the closing and will bear interest at a rate of 8% per annum from the date of issue, payable in cash, semi-annually in arrears.

“We are appreciative of the continued support from insiders and investors close to the Company  in this placement”, said Steve Saviuk , Valeo’s Chief Executive Officer. “This financing will strengthen our balance sheet at a time of three important product launches for Valeo, Enerzair® Breezhaler®, Atectura® Breezhaler® and Redesca™. Commercialized through two distinct sales forces, these products are key drivers to our growth over the coming years”.

The net proceeds of the Offering will be used for working capital and general corporate purposes.

Closing of the Private Placement is expected to occur on or about April 23, 2021 and is subject to regulatory approval including that of the CSE. The Company may pay finder’s fees on the non-insider portion of the Private Placement, in compliance with applicable securities laws. All securities issued in connection with the Private Placement will be subject to a statutory hold period of four months plus one day from the date of issuance in accordance with applicable securities legislation.

The issuance of Convertible Debentures to the insiders will be considered related party transactions within the meaning of Multilateral Instrument 61-101 (“MI 61-101”). The Company intends to rely on the exemptions from the requirements of MI 61-101 in respect of any Insider Participation.

This press release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.

About Valeo Pharma

Valeo Pharma is a Canadian pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Respiratory Diseases, Neurology, Oncology and Hospital Specialty Products. Headquartered in Kirkland, Quebec Valeo Pharma has all the required capabilities and the full infrastructure to register and properly manage its growing product portfolio through all stages of commercialization. For more information, please visit www.valeopharma.com and follow us on LinkedIn and Twitter .

Forward Looking Statements

This press release contains forward-looking statements about Valeo’s objectives, strategies and businesses that involve risks and uncertainties. These statements are “forward-looking” because they are based on our current expectations about the markets we operate in and on various estimates and assumptions. Actual events or results may differ materially from those anticipated in these forward-looking statements if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate.

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. 

Empower Clinics $CBDT.ca $EPWCF Kai Medical Lab Receives Order for Up To 5,000 Covid-19 Tests from Two Film & Television Productions in Excess Of $750,000 $DMTK $LMD.ca $DOC.ca $DOCRF $WELL.ca $PRN.ca

Posted by AGORACOM-JC at 8:36 AM on Wednesday, April 14th, 2021

  • Announced that Kai Medical Laboratory has received an order for COVID-19 RT-PCR tests that is anticipated to be in excess of $CAD 750,000 from two new film and television productions.

VANCOUVER, BC / April 14, 2021 / EMPOWER CLINICS INC. (CSE:CBDT) (Frankfurt:8EC) (OTCQB:EPWCF) (“Empower” or the “Company“) an integrated healthcare company – serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens, is pleased to announce that Kai Medical Laboratory (“KAI”) has received an order for COVID-19 RT-PCR tests that is anticipated to be in excess of $CAD 750,000 from two new film and television productions.

5,000 TEST ORDER FOR FILM & TELEVISION PRODUCTIONS REPRESENTS REPEAT ORDER BASED ON CONSISTENT PERFORMANCE OF KAI MEDICAL LAB

In early October, shortly after the acquisition of KAI, Empower announced an agreement to process approximately 1,000 COVID-19 RT-PCR tests for a major film & TV production over a 30-day period, with the possibility of more business upon successful completion of the initial tests.

On November 16, 2020 KAI received a repeat and record COVID-19 testing order for approximately 9,000 units in excess of $CAD 1,000,000 over a four-month period.

Today’s announcement represents a repeat Purchase Order of approximately 5,000 units to be processed over just a two-month period. The total revenue from this order is anticipated to be in excess of $CAN 750,000.

“Our team at KAI continues to deliver the type of performance to Tier-1 clients that is worthy of significant repeat business that serves as unequivocal validation of our capabilities,” said Steven McAuley, Chairman & CEO of Empower. “To this end, the magnitude of KAI’s growth and success cannot be overstated as it continues to focus on very active business development and product development, setting a path toward significant North American growth in the midst of tripling its size. KAI is well on its way to becoming a national brand supported by our strong working capital position and a team dedicated to performance.”

As of September 1st, KAI has already processed tests for multiple different film and television productions in key US markets including Los Angeles, Atlanta, New York, Dallas, earning the highest confidence of the industry.

KAI MEDICAL LABORATORY NOW EXPANDING TO TRIPLE CURRENT SIZE IN ANTICIPATION OF ANTICIPATED RAPID TEST GROWTH

On February 16th, Empower announced “KAI Laboratory Now Tripling in Size in Anticipation of Test Volumes by End of Q1”

KAI continues to progress on the design and build out of the laboratory expansion to prepare to meet upcoming demand in a number of areas. First, the continued processing of RT-PCR tests for film & television productions, commercial accounts and enterprise level clients. Second, the full e-commerce impact of KaiTests.com and the national direct-to-consumer marketing programs for KAI Saliva, an FDA, EUA authorized and Health Canada approved at-home Saliva COVID-19 RT-PCR Test. KAI Saliva provides travellers, both foreign and domestic with a simple, fully compliant method to obtain an RT-PCR test and test result prior to arriving or coming back into Canada and USA, or arriving in other countries that have similar executive travel orders.

Finally, KAI Labs continues the development of new direct-to-consumer test protocols that will expand the product offers on Kaitests.com throughout 2021 and beyond.

McAuley added “With each passing month Empower gains more strength and velocity in every aspect of our business from KAI Lab in Dallas to our rapidly expanding clinic operations in Canada and our direct-to-consumer products such as KAI Saliva. All of which are amply funded well into the future with our strongest balance sheet ever thanks to the receipt of more than $12,000,000 in warrant conversions as of last month. We are on a path, a trajectory towards building a great health and wellness company across North America, and I look forward to providing our shareholders with further specifics.”

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics

Read More: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/759019-empower-clinics-kai-medical-lab-receives-order-for-up-to-5-000-covid-19-tests-from-two-film-television-productions-in-excess-of-750-000/messages/2311867#message

Red Light Holland $TRIP.ca $TRUFF Enters into Letter of Intent to Acquire Controlling Stake in Happy Caps Mushroom Farm based in Halifax, Nova Scotia $RVV.ca $PSYC $FTRP $BUZZ

Posted by AGORACOM at 3:08 PM on Tuesday, April 13th, 2021
Corporate Logo
  • Acquiring 80% stake in Happy Caps Farm
  • Realizing synergies by introducing Happy Caps to Europe via wholly owned distribution company SR-Wholesale
  • Making mushroom growing easy and accessible

Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce it has entered into a non-binding letter of intent to acquire an 80% stake in Happy Caps Farm (“Happy Caps“), one of Nova Scotia’s most unique gourmet mushroom farms, cleverly positioned in the mushroom plug spawn business, selling fresh mushrooms for the wholesale market and specializing in ‘grow your own mushroom kits’.

“Now this gets me excited! Happy Caps’ founders, Andrew Kobayashi and Andrew Hatfield will be strong additions to Red Light Holland. Not only are we expected to purchase an 80% stake in their growing and profitable business, but we will also gain valuable intellectual property as Andrew and Andrew both possess strong mushroom growing expertise and capabilities,” said Todd Shapiro, CEO and Director of Red Light Holland. “There remain a few details to iron out, but everyone at Red Light Holland is extremely excited by the potential to grow our business, our brand and our revenues in our home country of Canada and we look forward to potentially realizing synergies by introducing Happy Caps to Europe via our wholly owned distribution company SR-Wholesale.”

“Getting to know Todd Shapiro and the entire team at Red Light Holland has been a pleasure so far,” said Andrew Kobayashi, CEO of Happy Caps “We are very experienced Mushroom growers and can work effectively with all types of genetics and strains. We are looking forward to working with Todd and his team to drive growth in our Happy Caps homegrow kits, where we help you grow your own mushrooms.”

“We are making mushroom growing easy and accessible, and Red Light Holland gets that! They also get how magical growing mushrooms can be, which is why we are excited to effect this transaction,” said Andrew Hatfield, CMO of Happy Caps. “We look forward to working as Red Light Holland’s Master Growers in Canada, and believe that together we can contribute to future growth in the ever-expanding mushroom industry.”

Further details of the proposed 80% acquisition will be announced once available.

About Happy Caps Farm

Happy Caps is an urban gourmet mushroom farm located in Halifax, Nova Scotia that specializes in quality ‘grow your own mushroom kits’, mushroom plug spawn and fresh mushrooms for the wholesale market. Grow your own Mushroom kits are available at www.HappyCaps.ca

About Red Light Holland Corp.

The Company is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/